For the treatment of patients with mild to moderate infections caused by susceptible strains of the designated micro-organisms in the specific conditions listed below:
- Lower respiratory
tract infections (acute bacterial bronchitis and community
acquired pneumonia in patients suitable for outpatient oral
treatment and in patients who require initial intravenous
- Upper respiratory
tract infections (acute sinusitis, acute streptococcal pharyngitis/tonsillitis
and acute otitis media in children).
Uncomplicated skin and skin structure infections.
transmitted diseases (uncomplicated urethritis and cervicitis).
Antimicrobial agents used in high doses for short periods
of times to treat non-gonococcal urethritis may mask or
delay the symptoms of incubating gonorrhea or syphilis.
All patients with sexually-transmitted urethritis or cervictitis
should have a serologic test for syphilis and appropriate
cultures for gonorrhea performed at the time of diagnosis.
Appropriate antimicrobial therapy and follow-up tests for
these diseases should be initiated if infection is confirmed.
Pelvic inflammatory disease in patients who require initial
of gastroduodenal ulcers induced by non-selective non-steroidal
anti-inflammatory drugs (NSAIDs) in patients at risk with
a need for continuous NSAID treatment.
Chlamydia trachomatis conjunctivitis and trachoma in adults
and in children 12 months or older.
Prophylaxis and treatment of disseminated mycobacterium
avium complex (MAC) disease in adults and children aged
more than 12 years.
Azithromycin is used to treat a wide variety of bacterial infections. It is a macrolide-type antibiotic. It works by stopping the growth of bacteria.
250 mg Tablets
500 mg Tablets
200 mg/5 mL Powder for Oral Suspension